|
|
|
Opening lecture
|
Geoffrey W. TREGEAR
 |
Howard Florey Institute, Australia |
"Relaxin: the journey from discovery to clinical trials" |
Plenary lectures
|
Alain BECK
 |
Centre d'Immunologie Pierre Fabre, France |
"Peptides as tools and drugs for immunotherapies" |
|
Michael J. BROWNSTEIN
 |
J. Craig Venter Institute, USA |
"Venomics: a primer" |
|
Patrick GARROUSTE
 |
Debio Group, Switzerland |
“Key issues in the development of peptide drugs” |
|
Alan HARVEY
 |
Strathclyde Institute for Drug Research, UK |
"Protease-activated receptors as targets for anti-inflammatory drug discovery" |
|
Stephen B.H. KENT
 |
University of Chicago, USA |
"Industrial chemical protein synthesis: what will it take to make it happen?" |
|
Per Holse MYGIND
 |
Novozymes A/S, Denmark |
"Plectasin, beyond nature – improving the natural peptide and developing a process for bioproduction" |
|
John P. MAYER
 |
Eli Lilly and Co., USA |
"Melanocortin peptides for obesity" |
|
Jennifer RIGGS-SAUTHIER
 |
Nektar Therapeutics, USA |
"The art of PEGylation: advancing peptide drugs into the Future" |
Closing lecture
|
George MILJANICH

|
Airmid LLC, USA |
"PRIALTÒ (ziconotide intrathecal infusion): a conopeptide for treating severe chronic pain"
|

|
No Keywords
|
Powered by v 3.9.6d © 2002-2004 All rights reserved
|